Exane Derivatives’s Robert Half RHI Stock Holding History

Exane Derivatives’s Portfolio RHI Stock Details RHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$184K	Buy	2,463 +1,082	+78%	+$103K	0.11%	180
2022 Q1	$158K	Buy	1,381 +1,005	+267%	+$116K	0.04%	388
2021 Q4	$41.9K	Sell	376 -372	-50%	-$41.4K	0.01%	512
2021 Q3	$75K	Sell	748 -293	-28%	-$28.7K	0.02%	573
2021 Q2	$90.5K	Buy	1,041 +3	+0.3%	+$262	0.02%	554
2021 Q1	$81K	Sell	1,038 -310	-23%	-$22.5K	0.02%	450
2020 Q4	$84.2K	Buy	1,348 +1,196	+787%	+$71.4K	0.02%	416
2020 Q3	$8.05K	Sell	152 -37,425	-100%	-$1.99M	﹤0.01%	478
2020 Q2	$1.99M	Sell	37,577 -11,176	-23%	-$531K	0.53%	52
2020 Q1	$1.84M	Sell	48,753 -6,316	-11%	-$342K	0.51%	48
2019 Q4	$3.47M	Buy	55,069 +55,067	+2,753,350%	+$3.2M	0.64%	53
2019 Q3	$111	Hold	2	–	–	﹤0.01%	635
2019 Q2	$114	Hold	2	–	–	﹤0.01%	637
2019 Q1	$130	Hold	2	–	–	﹤0.01%	574
2018 Q4	$114	Hold	2	–	–	﹤0.01%	638
2018 Q3	$141	Hold	2	–	–	﹤0.01%	611
2018 Q2	$130	Hold	2	–	–	﹤0.01%	600
2018 Q1	$113	Hold	2	–	–	﹤0.01%	545
2017 Q4	$111	Hold	2	–	–	﹤0.01%	541
2017 Q3	$101	Hold	2	–	–	﹤0.01%	508
2017 Q2	$96	Buy	+2	New	+$94	﹤0.01%	571
2017 Q1	–	Sell	-2	Closed	-$98	–	657
2016 Q4	$98	Hold	2	–	–	﹤0.01%	546
2016 Q3	$76	Hold	2	–	–	﹤0.01%	550
2016 Q2	$76	Hold	2	–	–	﹤0.01%	479
2016 Q1	$93	Hold	2	–	–	﹤0.01%	535
2015 Q4	$94	Hold	2	–	–	﹤0.01%	456
2015 Q3	$102	Hold	2	–	–	﹤0.01%	492
2015 Q2	$111	Sell	2 -356,517	-100%	-$20.4M	﹤0.01%	492
2015 Q1	$21.6M	Buy	356,519 +356,510	+3,961,222%	+$21.4M	2.38%	21
2014 Q4	$525	Buy	+9	New	+$488	﹤0.01%	486

Other funds holding RHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Exane Derivatives's RHI Position: Q2 2022 in Review

Exane Derivatives increased its Robert Half (RHI) stake by 78% in Q2 2022, buying an estimated $103K and bringing the position to 2,463 shares worth $184K. The position accounts for 0.11% of the portfolio, ranked #180.

Exane Derivatives first reported a position in RHI in Q4 2014 and has held it in 30 quarters since. The position peaked at $21.6M in Q1 2015. 587 funds tracked by Wall St. Rank hold RHI as of Q2 2022.

Exane Derivatives held 2,463 shares of Robert Half worth $184K as of Q2 2022.
Exane Derivatives bought 1,082 Robert Half shares in Q2 2022, an estimated $103K.
Robert Half made up 0.11% of Exane Derivatives's portfolio in Q2 2022, its #180 holding.
Exane Derivatives first reported a position in Robert Half in Q4 2014 and has held it in 30 quarters since.
Exane Derivatives's Robert Half position peaked at $21.6M in Q1 2015.
587 funds tracked by Wall St. Rank held Robert Half as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.